Teva Pharmaceutical Industries Ltd (NYSE:TEVA)
| 9.49 Delayed Data As of Dec 10 |  -0.33 / -3.36%Today’s Change | 6.07 Today|||52-Week Range 20.21 | -38.46% Year-to-Date |
Stock Price Forecast
The 18 analysts offering 12-month price forecasts for Teva Pharmaceutical Industries Ltd have a median target of 8.50, with a high estimate of 15.00 and a low estimate of 6.00. The median estimate represents a -10.43% decrease from the last price of 9.49.
Analyst Recommendations
The current consensus among 23 polled investment analysts is to Hold stock in Teva Pharmaceutical Industries Ltd. This rating has held steady since November, when it was unchanged from a rating.Move your mouse over past
months for detail
Earnings and Sales Forecasts
Current Quarter
Earnings per Share
$0.61
$0.61
Sales
$4.4B
$4.4B
Reporting Date
Feb 07
Feb 07
Earnings per Share
Move your mouse over a quarter or year to see how estimates have changed over time.
Growthquarterly 4.83%
Growthannually -18.37%
Sales
Growthquarterly 2.11%
Growthannually -8.70%
